vs
Host Hotels & Resorts（HST）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
Host Hotels & Resorts的季度营收约是瑞思迈的1.1倍（$1.6B vs $1.4B），瑞思迈净利率更高（27.6% vs 8.4%，领先19.2%），Host Hotels & Resorts同比增速更快（12.3% vs 11.0%），Host Hotels & Resorts自由现金流更多（$445.0M vs $311.2M），过去两年瑞思迈的营收复合增速更高（9.0% vs 4.4%）
Host Hotels & Resorts是总部位于美国马里兰州贝塞斯达的房地产投资信托企业，专注于高端酒店资产投资。截至2024年12月31日，公司在美国、巴西、加拿大共持有81家高端酒店，总客房数约4.34万间，是全球知名的酒店不动产投资机构。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
HST vs RMD — 直观对比
营收规模更大
HST
是对方的1.1倍
$1.4B
营收增速更快
HST
高出1.3%
11.0%
净利率更高
RMD
高出19.2%
8.4%
自由现金流更多
HST
多$133.8M
$311.2M
两年增速更快
RMD
近两年复合增速
4.4%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.4B |
| 净利润 | $135.0M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 12.0% | 34.6% |
| 净利率 | 8.4% | 27.6% |
| 营收同比 | 12.3% | 11.0% |
| 净利润同比 | 25.0% | 13.9% |
| 每股收益（稀释后） | $0.20 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HSTRMD
| Q4 25 | $1.6B | $1.4B | ||
| Q3 25 | $1.3B | $1.3B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.4B | $1.3B | ||
| Q3 24 | $1.3B | $1.2B | ||
| Q2 24 | $1.5B | $1.2B | ||
| Q1 24 | $1.5B | $1.2B |
净利润HSTRMD
| Q4 25 | $135.0M | $392.6M | ||
| Q3 25 | $161.0M | $348.5M | ||
| Q2 25 | $221.0M | $379.7M | ||
| Q1 25 | $248.0M | $365.0M | ||
| Q4 24 | $108.0M | $344.6M | ||
| Q3 24 | $82.0M | $311.4M | ||
| Q2 24 | $239.0M | $292.2M | ||
| Q1 24 | $268.0M | $300.5M |
毛利率HSTRMD
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率HSTRMD
| Q4 25 | 12.0% | 34.6% | ||
| Q3 25 | 7.6% | 33.4% | ||
| Q2 25 | 17.5% | 33.7% | ||
| Q1 25 | 17.9% | 33.0% | ||
| Q4 24 | 11.0% | 32.5% | ||
| Q3 24 | 10.2% | 31.6% | ||
| Q2 24 | 19.9% | 31.2% | ||
| Q1 24 | 19.8% | 31.3% |
净利率HSTRMD
| Q4 25 | 8.4% | 27.6% | ||
| Q3 25 | 12.1% | 26.1% | ||
| Q2 25 | 13.9% | 28.2% | ||
| Q1 25 | 15.6% | 28.3% | ||
| Q4 24 | 7.6% | 26.9% | ||
| Q3 24 | 6.2% | 25.4% | ||
| Q2 24 | 16.3% | 23.9% | ||
| Q1 24 | 18.2% | 25.1% |
每股收益（稀释后）HSTRMD
| Q4 25 | $0.20 | $2.68 | ||
| Q3 25 | $0.23 | $2.37 | ||
| Q2 25 | $0.32 | $2.58 | ||
| Q1 25 | $0.35 | $2.48 | ||
| Q4 24 | $0.15 | $2.34 | ||
| Q3 24 | $0.12 | $2.11 | ||
| Q2 24 | $0.34 | $1.97 | ||
| Q1 24 | $0.38 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $768.0M | $1.4B |
| 总债务越低越好 | $1.3B | $403.9M |
| 股东权益账面价值 | $6.6B | $6.3B |
| 总资产 | $13.0B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.19× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资HSTRMD
| Q4 25 | $768.0M | $1.4B | ||
| Q3 25 | $539.0M | $1.4B | ||
| Q2 25 | $490.0M | $1.2B | ||
| Q1 25 | $428.0M | $932.7M | ||
| Q4 24 | $554.0M | $521.9M | ||
| Q3 24 | $564.0M | $426.4M | ||
| Q2 24 | $805.0M | $238.4M | ||
| Q1 24 | $1.3B | $237.9M |
总债务HSTRMD
| Q4 25 | $1.3B | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | $896.0M | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益HSTRMD
| Q4 25 | $6.6B | $6.3B | ||
| Q3 25 | $6.7B | $6.1B | ||
| Q2 25 | $6.6B | $6.0B | ||
| Q1 25 | $6.7B | $5.5B | ||
| Q4 24 | $6.6B | $5.3B | ||
| Q3 24 | $6.7B | $5.2B | ||
| Q2 24 | $6.8B | $4.9B | ||
| Q1 24 | $6.7B | $4.6B |
总资产HSTRMD
| Q4 25 | $13.0B | $8.5B | ||
| Q3 25 | $13.0B | $8.3B | ||
| Q2 25 | $13.0B | $8.2B | ||
| Q1 25 | $12.9B | $7.6B | ||
| Q4 24 | $13.0B | $7.1B | ||
| Q3 24 | $13.1B | $7.2B | ||
| Q2 24 | $12.4B | $6.9B | ||
| Q1 24 | $12.5B | $6.8B |
负债/权益比HSTRMD
| Q4 25 | 0.19× | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | 0.14× | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $543.0M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $445.0M | $311.2M |
| 自由现金流率自由现金流/营收 | 27.8% | 21.9% |
| 资本支出强度资本支出/营收 | 6.1% | 2.0% |
| 现金转化率经营现金流/净利润 | 4.02× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $1.2B | $1.8B |
8季度趋势，按日历期对齐
经营现金流HSTRMD
| Q4 25 | $543.0M | $339.7M | ||
| Q3 25 | $218.0M | $457.3M | ||
| Q2 25 | $444.0M | $538.8M | ||
| Q1 25 | $305.0M | $578.7M | ||
| Q4 24 | $331.0M | $308.6M | ||
| Q3 24 | $349.0M | $325.5M | ||
| Q2 24 | $453.0M | $440.1M | ||
| Q1 24 | $365.0M | $402.0M |
自由现金流HSTRMD
| Q4 25 | $445.0M | $311.2M | ||
| Q3 25 | $143.0M | $414.4M | ||
| Q2 25 | $381.0M | $508.2M | ||
| Q1 25 | $259.0M | $557.9M | ||
| Q4 24 | $235.0M | $288.0M | ||
| Q3 24 | $262.0M | $307.7M | ||
| Q2 24 | $409.0M | $415.2M | ||
| Q1 24 | $332.0M | $380.8M |
自由现金流率HSTRMD
| Q4 25 | 27.8% | 21.9% | ||
| Q3 25 | 10.7% | 31.0% | ||
| Q2 25 | 24.0% | 37.7% | ||
| Q1 25 | 16.2% | 43.2% | ||
| Q4 24 | 16.5% | 22.5% | ||
| Q3 24 | 19.9% | 25.1% | ||
| Q2 24 | 27.9% | 33.9% | ||
| Q1 24 | 22.6% | 31.8% |
资本支出强度HSTRMD
| Q4 25 | 6.1% | 2.0% | ||
| Q3 25 | 5.6% | 3.2% | ||
| Q2 25 | 4.0% | 2.3% | ||
| Q1 25 | 2.9% | 1.6% | ||
| Q4 24 | 6.7% | 1.6% | ||
| Q3 24 | 6.6% | 1.5% | ||
| Q2 24 | 3.0% | 2.0% | ||
| Q1 24 | 2.2% | 1.8% |
现金转化率HSTRMD
| Q4 25 | 4.02× | 0.87× | ||
| Q3 25 | 1.35× | 1.31× | ||
| Q2 25 | 2.01× | 1.42× | ||
| Q1 25 | 1.23× | 1.59× | ||
| Q4 24 | 3.06× | 0.90× | ||
| Q3 24 | 4.26× | 1.05× | ||
| Q2 24 | 1.90× | 1.51× | ||
| Q1 24 | 1.36× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HST
暂无分部数据
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
